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Introduction: Mycobacterium europaeum, a slow-growing nontuberculous mycobacteria belonging to the Mycobacterium
simiae complex, was described after the seminal characterization of five isolates collected from three sputum specimens
and a jaw gland biopsy in Italy, Greece and Sweden. Five respiratory tract isolates were further reported in Iran. Here,
we report the first isolation of M. europaeum in France, in the respiratory tract of a patient co-infected with human
immunodeficiency virus and hepatitis C virus.
Case presentation: A 49-year-old Caucasian woman with a 26-year history of human immunodeficiency virus-hepatitis
C virus co-infection was admitted for significant influenza-like syndrome in a context of repetitive exacerbations of
chronic obstructive pulmonary disease. Significant biological parameters included lymphocytes of 1.6G/L including
237/mm3 T4 lymphocytes, a human immunodeficiency virus viral load of 1.6 log and a hepatitis C virus viral load of 6
log. Reverse-transcriptase polymerase chain reaction of her nasopharyngeal aspiration confirmed influenza A H1N1.
Three sputum specimens lacked acid-fast bacilli but one grew mycobacteria identified by using matrix-assisted laser
desorption ionization/time-of-flight mass spectrometry as M. europaeum with a 1.56 log score. A 1,482-bp 16S
ribosomal ribonucleic acid gene sequence yielded 99% similarity with both Mycobacterium parascrofulaceum
ATCC BAA-614 and M. europaeum DSM 45397T and partial rpoB polymerase chain reaction-sequencing yielded a
725-bp sequence exhibiting 100% similarity with M. europaeum strain DSM 45397T.
Conclusions: We report the first isolation of M. europaeum in France, in the respiratory tract of a patient co-infected with
human immunodeficiency virus and hepatitis C virus. M. europaeum warrants further attention in immunosuppressed
patients with influenza, using matrix-assisted laser desorption ionization/time-of-flight mass spectrometry and
rpoB partial sequencing as tools for its accurate identification.
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Mycobacterium europaeum, a slow-growing nontubercu-
lous mycobacteria (NTM) belonging to the Mycobacter-
ium simiae complex, was described after the seminal
characterization of five isolates collected from three spu-
tum specimens and a jaw gland biopsy in Italy, Greece
and Sweden [1]. Five respiratory tract isolates were fur-
ther reported in Iran [2] from two different infected* Correspondence: michel.drancourt@univ-amu.fr
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unless otherwise stated.patients according to the American Thoracic Society/In-
fectious Diseases Society of America (ATS/IDSA criteria
for NTM lung disease [3]. In fact, ATS/IDSA criteria for
NTM lung infection combine clinical pulmonary cri-
teria, new radiological opacities, and, positive culture re-
sults from several respiratory tract samples [3]. Here, we
report the first isolation of M. europaeum in France, in
the respiratory tract of a patient co-infected with human
immunodeficiency virus (HIV) and hepatitis C virus
(HCV).
Case presentation
A 49-year-old Caucasian woman with a 26-year history
of HIV-HCV co-infection was admitted to an Infectioustral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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in February 2014 for significant influenza-like syndrome
in a context of repetitive exacerbations of chronic obstruct-
ive pulmonary disease. Pulmonary auscultation found dif-
fuse wheezing. Significant biological parameters included a
C-reactive protein level of 57mg/L, lymphocytes of 1.6G/L
including 237/mm3 T4 lymphocytes, a HIV viral load of
1.6 log and a HCV viral load of 6 log. Her chest radiog-
raphy was normal. Reverse-transcriptase polymerase chain
reaction (PCR) of her nasopharyngeal aspiration confirmed
influenza A H1N1. At a 6-month follow-up, her clinical
outcome was favorable with initial supportive treatment
only. Three sputum specimens lacked acid-fast bacilli
(AFB) after Ziehl–Neelsen staining and microscopic obser-
vation but one grew AFB after 21-day incubation in MGIT
(Becton Dickinson, Le Pont-de-Claix, France) at 37°C in a
5% carbon dioxide atmosphere. After subculture on Colet-
sos (bioMérieux, La-Balme-les-Grottes, France), the isolate
was deposited in our collection (CSUR P1344) and ten-
tatively identified by using matrix-assisted laser desorption
ionization/time-of-flight mass spectrometry (MALDI-TOF-
MS), the bioMérieux extraction protocol, a MicroFlex™
mass spectrometer (Bruker Daltonics, Bremen, Germany)
and the Bruker MALDI Biotyper procedures as previously
described [4]. A reproducible profile (Figure 1A) yielded a
1.56 log score with M. europaeum DSM 45397T listed in
the Bruker Mycobacterium Library 1.0 and 2.0 databases.
A 1,482-bp 16S ribosomal ribonucleic acid (rRNA)
gene sequence (GenBank LN680852) yielded 99% simi-
larity with both Mycobacterium parascrofulaceum ATCC
BAA-614 (GenBank GQ153273) and M. europaeum DSM
45397T (GenBank HM022196), two species known toFigure 1 Matrix-assisted laser desorption ionization/ time-of-flight anal
ionization/time-of-flight mass spectrometry profile of Mycobacterium europa
medium. B. Phylogenetic tree constructed using the neighbor-joining meth
correction model based on rpoB partial sequences of 18 mycobacterial spe
Bootstrap values above 90% are given at nodes. Mycobacterium tuberculosis
in nucleotide sequences. GenBank accession numbers are given in parenthshare almost identical 16S rRNA gene sequence [1].
Partial rpoB PCR-sequencing [5] yielded a 725-bp sequence
(GenBank LK021335) exhibiting 100% similarity with
M. europaeum strain DSM 45397T (GenBank HM022215;
Figure 1B).
Here, one M. europaeum isolate was made from broth
culture whereas the eight previous isolates have been
made from agar or egg-based solid medium [1,2], illus-
trating the capability of automatons routinely used in
laboratories, to detect the growth of M. europaeum.
Starting from colonies, this isolate was identified by
MALDI-TOF-MS and its profile made freely available
at Méditerranée Infection Foundation URMS Database
[6] in order to complement the sole profile (M. europaeum
DSM 45397T) commercially available.
Conclusions
M. europaeum has not been previously reported in
France. Three of the five seminal strains have been iso-
lated from sputum. Of interest, two Iranian patients [2]
with a history of acquired immunodeficiency syndrome
and cystic fibrosis fulfilled the ATS/IDSA criteria for
NTM pulmonary infection [3]. Here, clinical, radio-
logical and microbiological findings classified this case
as a colonized case [3]. As our understanding about the
pathophysiology of M. europaeum lung infection is in-
sufficient, there is not enough known to be sure that
colonization is not in fact a slowly progressive infection.
In addition, like other species of the M. simiae complex
[7,8], this new species could be clinically relevant when
isolated in the respiratory tract of immunocompromised
hosts. In fact, NTM should be investigated in theysis of Mycobacterium europaeum. A. Matrix-assisted laser desorption
eum CSUR P1344 using colonies from egg-based Löwenstein–Jensen
od (bootstrapped 1000 times) and Kimura’s two-parameter distance
cies including isolate CSUR P1344 collected in our patient’s sputum.
H37Rv was used as out-group. The scale bar represents 1% difference
eses. M. is Mycobacterium.
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because of a higher risk of lung infection that needs particu-
lar treatment [3]. Of interest, M. europaeum was here iso-
lated in a patient with laboratory-confirmed influenza, a
condition previously associated with Mycobacterium
tuberculosis infection [9] through virus-induced interfer-
ence in the interferon pathway [10]. Interactions between
influenza and superinfecting mycobacteria, particularly
NTM in the respiratory tract, warrant further attention to
be elucidated.
Consent
Written informed consent was obtained from the patient
for publication of this case report and any accompanying
images. A copy of the written consent is available for re-
view by the Editor-in-Chief of this journal.
Competing interest
The authors declare that they have no competing interests.
Authors’ contributions
MP, MDe, PB and MDr designed the study, drafted and revised the
manuscript. PB and MDr performed medical examinations. All authors have
read and approved the final manuscript.
Acknowledgments
This study was supported by URMITE, Marseille, France.
Received: 4 September 2014 Accepted: 2 December 2014
Published: 25 December 2014
References
1. Tortoli E, Böttger EC, Fabio A, Falsen E, Gitti Z, Grottola A, Klenk HP,
Mannino R, Mariottini A, Messinò M, Pecorari M, Rumpianesi F:
Mycobacterium europaeum sp. nov., a scotochromogenic species related
to the Mycobacterium simiae complex. Int J Syst Evol Microbiol 2011,
61:1606–1611.
2. Pourahmad F, Shojaei H, Heidarieh P, Khosravi A, Hashemi A: Report of two
cases of Mycobacterium europaeum from Iran. Jpn J InfecT Dis 2012,
65:539–541.
3. Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F,
Holland SM, Horsburgh R, Huitt G, Iademarco MF, Iseman M, Olivier K,
Ruoss S, von Reyn CF, Wallace RJ Jr, Winthrop K, ATS Mycobacterial Diseases
Subcommittee; American Thoracic Society; Infectious Disease Society of
America: An official ATS/IDSA statement: diagnosis, treatment, and
prevention of nontuberculous mycobacterial diseases. Am J Respir Crit
Care Med 2007, 175:367–416.
4. Mather C, Rivera S, Butler-Wu S: Comparison of the Bruker Biotyper and
Vitek MS matrix-assisted laser desorption ionization – time of flight mass
spectrometry systems for identification of mycobacteria using simplified
protein extraction protocols. J Clin Microbiol 2014, 51:130–138.
5. Adékambi T, Colson P, Drancourt M: rpoB-based identification of
nonpigmented and late-pigmented rapidly growing mycobacteria. J Clin
Microbiol 2003, 41:5699–5708.
6. Méditerranée Infection Foundation URMS Database. [http://www.mediterranee-
infection.com/article.php?laref=256&titre=urms-database]
7. Centers for Disease Control and Prevention: Disseminated infection with
simiae-avium group mycobacteria in persons with AIDS – Thailand and
Malawi, 1997. Morbid Mortal Wkly Rep 2002, 51:501–502.
8. Cruz AT, Goytia VK, Starke JR: Mycobacterium simiae complex infection in
an immunocompetent child. J Clin Microbiol 2007, 45:2745–2746.
9. Tan CK, Kao CL, Shih JY, Lee LN, Hung CC, Lai CC, Huang YT, Hsueh PR:
Coinfection with Mycobacterium tuberculosis and pandemic H1N1influenza in a patient with lung cancer. J Microbiol Immunol Infect 2011,
44:316–318.
10. Redford PS, Mayer-Barber KD, McNab FW, Stavropoulos E, Wack A, Sher A,
O’Garra A: Influenza A virus impairs control of Mycobacterium tuberculosis
coinfection through a type I interferon receptor-dependent pathway.
J Infect Dis 2014, 209:270–274.
doi:10.1186/1752-1947-8-463
Cite this article as: Phelippeau et al.: Respiratory tract isolation of
Mycobacterium europaeum following influenza infection in an
immunocompromised patient: a case report. Journal of Medical Case
Reports 2014 8:463.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
